Related Experiment Video
Updated: May 13, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Assessing whether there is a cancer premium for the value of a statistical life
W Kip Viscusi1, Joel Huber, Jason Bell
1University Distinguished Professor of Law, Economics, and Management, Vanderbilt University, Nashville, TN, USA.
Abstract:
This article estimates whether there is a cancer risk premium for the value of a statistical life using stated preference valuations of cancer risks for a large, nationally representative US sample. The present value of an expected cancer case that occurs after a one decade latency period is $10.85m, consistent with a cancer premium that is 21% greater than the median value of a statistical life estimates for acute fatalities. This cancer premium is smaller than the premium proposed for policy analyses in the UK and the USA. There is also a greater premium for policies that reduce cancer risks to zero and for risk reductions affecting those who perceive themselves to have a greater than average probability of having cancer.
Related Concept Videos
Cancer Survival Analysis
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach
Assumptions of Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Statistical Methods for Analyzing Epidemiological Data
